schizophrenia

May 02 2025

Uncategorized

Schizophrenic man testifies ‘demonic voice’ took over when he slashed Kelowna officer’s face

by Clinical Editor

No Comments

A schizophrenic man who’s accused of the attempted murder of a Kelowna RCMP officer told the court that a demonic voice had taken control of his body when he slashed...

May 01 2025

Uncategorized

Fewer Typical Suicide Factors Observed After Recent Schizophrenia Diagnosis

by Clinical Editor

No Comments

Recent onset of schizophrenia or other primary psychotic disorders may need intensive support for lives disrupted by their diagnosis.

May 01 2025

Uncategorized

LSD analogue synthesised by swapping just two atoms less likely to cause hallucinations

by Clinical Editor

No Comments

An analogue of the psychedelic drug LSD has been found to offer the same therapeutic effects as LSD but is less likely to cause the hallucinogenic trips associated with the...

Apr 30 2025

Uncategorized

MERIT Therapy for Schizophrenia and Serious Mental Illness

by Clinical Editor

No Comments

MERIT is one of several metacognitive psychotherapies, designed especially to meet the needs of individuals living with serious mental illnesses, including schizophrenia. It is deliverable in both …

Apr 30 2025

Uncategorized

Cannabis Use Disorder Linked to Psychosis Brain Changes

by Clinical Editor

No Comments

New research shows that individuals with cannabis use disorder have elevated dopamine levels in brain regions associated with psychosis.

Apr 29 2025

Uncategorized

Could eye scans spot schizophrenia early? New research offers hope for early detection

by Clinical Editor

No Comments

Eyes have long been called a window to the world — but new research suggests they may also reveal the state of a person’s mental health. New study by a...

Apr 29 2025

Uncategorized

Defense secretary orders review of medical standards for military enlistment

by Clinical Editor

No Comments

Defense Secretary Pete Hegseth signed a memorandum, April 24, 2025, directing a comprehensive review of medical conditions that …

Apr 28 2025

Uncategorized

Cobenfy as an Adjunctive Agent in Schizophrenia: Peter J. Weiden, MD, Shares Insights on the Latest Findings – Psychiatric Times

by Clinical Editor

No Comments

Cobenfy as an Adjunctive Agent in Schizophrenia: Peter J. Weiden, MD, Shares Insights on the Latest Findings  Psychiatric Times

Apr 28 2025

Uncategorized

Neuroleptic Malignant Syndrome Following Brexpiprazole Initiation in a Treatment-Resistant Schizophrenia Patient With Influenza A: A Case Report – Cureus

by Clinical Editor

No Comments

Neuroleptic Malignant Syndrome Following Brexpiprazole Initiation in a Treatment-Resistant Schizophrenia Patient With Influenza A: A Case Report  Cureus

Apr 27 2025

Uncategorized

Bristol Myers’ Cobenfy fails in key study as add-on treatment for schizophrenia

by Clinical Editor

No Comments

By Sriparna Roy (Reuters) -Bristol Myers Squibb said on Tuesday its drug Cobenfy failed to show a statistically significant difference in a keenly watched late-stage trial that would help expand...